Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.
about
Escaping Antiangiogenic Therapy: Strategies Employed by Cancer CellsA self-assembling nanomedicine of conjugated linoleic acid-paclitaxel conjugate (CLA-PTX) with higher drug loading and carrier-free characteristic.Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix.Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer.The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles.
P2860
Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multi-targeting NGR-modified l ...... improving anti-glioma therapy.
@en
Multi-targeting NGR-modified l ...... improving anti-glioma therapy.
@nl
type
label
Multi-targeting NGR-modified l ...... improving anti-glioma therapy.
@en
Multi-targeting NGR-modified l ...... improving anti-glioma therapy.
@nl
prefLabel
Multi-targeting NGR-modified l ...... improving anti-glioma therapy.
@en
Multi-targeting NGR-modified l ...... improving anti-glioma therapy.
@nl
P2093
P2860
P356
P1433
P1476
Multi-targeting NGR-modified l ...... improving anti-glioma therapy.
@en
P2093
Shu-Shi Zhang
Shuang Zhang
Ting Zhong
Xiao-Chuan Duan
Xuan Zhang
Yi-Fan Yin
P2860
P304
43616-43628
P356
10.18632/ONCOTARGET.9889
P407
P577
2016-06-07T00:00:00Z